Delta-opioid receptor antagonists as a new concept for central acting antitussive drugs
- PMID: 12099770
- DOI: 10.1006/pupt.2002.0350
Delta-opioid receptor antagonists as a new concept for central acting antitussive drugs
Abstract
Our recent findings indicated that mu- and kappa-opioid receptors enhance each other's antitussive processes. However, delta-opioid receptors played an inhibitory role in antitussive processes mediated by the mu- and kappa-opioid receptors. We also concluded that delta(1)-opioid receptors may play an inhibitory role, whereas delta(2)-opioid receptors may play a synergistic role, in antitussive processes mediated by mu-opioid receptors. Furthermore, we clearly demonstrated that delta-opioid receptor antagonists, such as naltrindole and 7-benzylidenenaltrexone, produced potent antitussive effects. These delta-opioid receptor-mediated antitussive effects may be mediated by the antagonism of delta(1)-, but not delta(2)-opioid receptors. In this review, we study the possibility of the delta-opioid receptor antagonist as a new concept for central acting antitussive drugs.
Copyright 2002 Elsevier Science Ltd.
Comment in
-
Summary: central nervous pharmacology of cough.Pulm Pharmacol Ther. 2002;15(3):251-2. doi: 10.1006/pupt.2002.0339. Pulm Pharmacol Ther. 2002. PMID: 12099773 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
